CDAN1 p.Pro268Arg
c.803C>G · rs151004903 · VCV2439834
Computational evidence
| Protein change | ||
| AlphaMissense | 0.0859 | likely benign |
|---|---|---|
| REVEL | 0.381 | indeterminate |
| SaProt | LLR -7.71 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 5.1 | GERP 1.2, phastCons 1 |
| Regional constraint | o/e 1.15 | unconstrained · MANE · 1,562 bp · p 0.0016 · regional, not allelic |
| Overall | ||
| CADD | 21.7 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| African / African-Americangrpmax | 0.0174% | 5,761 |
| European (non-Finnish) | 0.00195% | 51,305 |
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,484 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CDAN1
- Protein
- p.Pro268Arg
- Coding
- c.803C>G
- MANE Select
- NM_138477
- dbSNP
- rs151004903
- Type
- single nucleotide variant
- Location
- chr15:42735650 (GRCh38)
- Gene constraint
- LOEUF 0.908 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 72.58 · 2 PDB
- Residue 268
- the 'disordered' region
Disease context
anemia, congenital dyserythropoietic, type 1a — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Congenital dyserythropoietic anemia type I (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Infancy, Neonatal
- Prevalence
- <1 / 1 000 000 (Europe)
Similar variants
- CDAN1 p.Pro268= Benign/Likely benign ★★ same residue
- CDAN1 p.Pro268Ser Uncertain significance ★ ⚠ same residue
- CDAN1 p.Arg1042Trp Pathogenic/Likely pathogenic ★★ ⚠ same condition
- CDAN1 p.Arg682Ter Pathogenic ★★ same condition
- CDAN1 p.Arg714Trp Pathogenic/Likely pathogenic ★★ ⚠ same condition
- CDAN1 p.Asn599Ser Likely pathogenic ★★ ⚠ same condition
- CDAN1 p.Phe52Leu Pathogenic/Likely pathogenic ★★ ⚠ same condition
- CDAN1 p.Pro1130Leu Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cdan1-p-pro268arg (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown